In Conversation with Kenvue’s Transactions Legal Team

The 2023 separation of Johnson & Johnson’s consumer health business into a standalone S&P 500® company, Kenvue Inc., marked a significant milestone in corporate restructuring. It was not just a complex business transaction but also a defining moment for both companies, bringing iconic brands like Tylenol®, Listerine®, BAND-AID® Brand and Neutrogena® to a new home […]

In Conversation with Kenvue’s Transactions Legal Team Read More »